Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Yujin Shuto"'
Autor:
Cyril Esnault, Hiroshi Maegawa, Yujin Shuto, Daisuke Koya, Mathilde Berthelot, Yuki Tajima, Dian Kang, Hirotaka Watada, Fang L. Zhou
Publikováno v:
Diabetes, Obesity & Metabolism
Aims To investigate the effects of sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors vs. dipeptidyl peptidase‐4 (DPP‐4) inhibitors on renal function preservation (RFP) using real‐world data of patients with type 2 diabetes in Japan, and
Autor:
Yujin Shuto, Dena H Jaffe, Cheryl Teoh, Xiahong Zhao, Yasuo Terauchi, Yuki Tajima, Asuka Ozaki
Publikováno v:
Diabetes Research and Clinical Practice. 149:115-125
Aim This study aims to examine the humanistic and economic burden of cardiovascular disease (CVD)-related comorbidities and hypoglycaemia among respondents with type 2 diabetes (T2D) in Japan. Methods This study used the Japan National Health and Wel
Autor:
Hirotaka Watada, Daisuke Koya, Yujin Shuto, Fang Liz Zhou, Yuki Tajima, Hiroshi Maegawa, Dian Kang, Cyril Esnault, Mathilde Berthelot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bc17a5e5ae0d66e1a417800aeb9e249
https://doi.org/10.1111/dom.13753/v2/response1
https://doi.org/10.1111/dom.13753/v2/response1
Autor:
Yuichiro, Yamada, Masayuki, Senda, Yusuke, Naito, Masahiro, Tamura, Daisuke, Watanabe, Yujin, Shuto, Yoshihisa, Urita
Publikováno v:
Diabetes, Obesity & Metabolism
Aim To evaluate the pharmacodynamics of lixisenatide once daily vs sitagliptin once daily in Japanese patients with type 2 diabetes receiving insulin glargine U100. Materials and methods This multicentre, open‐label, phase IV study (NEXTAGE Study;
Publikováno v:
Journal of Diabetes Mellitus. :273-289
Aims: In the Add-on Lantus® to Oral Hypoglycaemic Agents 2 (ALOHA 2) Study in Japanese adults with type 2 diabetes mellitus (T2DM), data on the safety and efficacy of combination therapy with insulin glargine (Lantus®) and oral anti-hyperglycaemic
Autor:
Hirotaka Watada, Kazuyuki Tobe, Yujin Shuto, Kohei Kaku, Narihito Yoshioka, Takashi Kadowaki, Mitsuyoshi Namba, Yasuo Terauchi, Kohjiro Ueki, Yuichiro Yamada, Eiichi Araki
Publikováno v:
Diabetology International. 3:11-20
The PREDICTIVETM Study of Japan was an open-label, non-randomized 52-week observational study to evaluate the safety and efficacy of insulin detemir when used in routine clinical practice. Patients with either type 1 or 2 diabetes in whom insulin det
Publikováno v:
Current Medical Research and Opinion. 27:643-650
To evaluate treatment satisfaction before and after starting biphasic insulin aspart 30 (BIAsp 30) therapy in patients with type 2 diabetes mellitus (T2D) in the IMPROVE study Japan using the Diabetes Medication Satisfaction (DiabMedSat) questionnair
Publikováno v:
Annals of the New York Academy of Sciences. 805:684-691
Autor:
Ishwar S. Parhar, Ken Wada, Hitoshi Sugihara, Jun Kamegai, Yujin Shuto, Ichiji Wakabayashi, Tamotsu Shibasaki, Shinichi Oikawa
Publikováno v:
Life Sciences. 68:991-996
Growth hormone (GH) secretagogues (GHSs), which stimulate GH secretion, are synthetic compounds that act through the GHS receptor (GHS-R) which has been recently cloned. We raised an antiserum in a rabbit against a synthetic peptide corresponding to
Publikováno v:
Neuroendocrinology. 69:217-226
Pituitary adenylate cyclase-activating polypetide (PACAP) exists in two amidated forms, PACAP38 and PACAP27, which are expressed in the magnocellular and parvocellular neurons of the paraventricular nucleus (PVN) and the magnocellular neurons of the